Evaluation of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiation for Non-resectable Stage III NSCLC
Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate whether by combining a carboplatin-gemcitabine based
induction chemotherapy with weekly cisplatin during standard thoracic radiotherapy it is
possible to obtain optimal efficacy with minimal toxicity. Patients will be treated with 3
cycles of induction chemotherapy, unless there is the occurrence of early intrathoracic
progression of disease. The induction chemotherapy is then to be followed by
chemo-radiotherapy.